Search

everythinglearnresearchcommunity

for

Search:↓

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

People with Alopecia Areata are more likely to have certain health issues like ulcerative colitis and type 1 diabetes, but less likely to have others like hypertension and type 2 diabetes.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Higher IL-17A levels indicate more severe alopecia areata.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Certain blood cell ratios are higher in kids with alopecia areata and might help predict the disease.

Finding eosinophils near hair bulbs helps diagnose alopecia areata.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

A woman with severe angioedema improved significantly after treatment with rituximab.

Machine learning can use blood tests to help predict moderate-to-severe alopecia areata.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Amyloid deposits linked to a type of protein may cause a unique pattern of hair loss by disrupting hair growth cycles.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Higher levels of retinol-binding protein 4 are found in people with alopecia areata, but these levels don't relate to how severe the condition is.

The study identified key immune cell differences between mild and severe alopecia areata.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Platelet-rich plasma treatment is effective for hair loss in patients regardless of their thyroid antibody levels.

Alopecia areata is caused by the immune system attacking hair follicles.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

The letter suggests that the study's comparison group might have affected the results and calls for larger, more detailed future research.

Tranexamic acid effectively reduced swelling episodes in a girl with a rare form of hereditary angioneurotic edema.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.